Wolverine XR | BPC-157 10 mg + TB-500 2.5 mg + MGF 1 mg + KPV 1 mg

$89.00

Wolverine XR is a four-compound research blend containing BPC-157 10 mg, TB-500 2.5 mg, MGF 1 mg, and KPV 1 mg. Its individual components have been investigated in experimental models involving connective tissue biology, cellular migration, muscle cell signaling, and inflammatory regulation. This 14.5 mg blend is intended exclusively for controlled laboratory research. Not for human consumption.

In Stock

-
+
Categories: , ,

Wolverine XR | BPC-157, TB-500, MGF & KPV Blend

BPC-157 10 mg • TB-500 2.5 mg • MGF 1 mg • KPV 1 mg
Total Research Compound Content: 14.5 mg

Introduction

Wolverine XR combines four research compounds investigated for their involvement in cellular migration, connective tissue biology, muscle cell signaling, and inflammatory regulation. This formulation contains BPC-157, TB-500, mechano growth factor (MGF), and the tripeptide KPV.

Each component brings a different area of experimental interest. BPC-157 has been examined in tendon and fibroblast models, while TB-500 is associated with an active region of thymosin beta-4, a protein involved in actin interactions and cellular movement. Synthetic MGF peptides have been investigated in muscle progenitor cell research, and KPV has been studied for its effects on inflammatory signaling in intestinal epithelial and immune cells.

These areas provide a rationale for investigating the compounds together. However, published findings on individual ingredients do not establish the activity, safety, or synergistic effects of this specific four-compound formulation.

Background and Mechanism

BPC-157

BPC-157 is a synthetic pentadecapeptide consisting of 15 amino acids. Experimental studies have investigated its effects on tendon fibroblast migration, cellular survival under oxidative stress, and tissue organization.

Research involving rat tendon explants and cultured fibroblasts reported increased tendon outgrowth and cell migration, with activation of the focal adhesion kinase (FAK) and paxillin signaling pathway proposed as a contributing mechanism. These findings concern laboratory models rather than demonstrated clinical outcomes.

TB-500

TB-500 is a name used for synthetic material associated with the actin-binding region of thymosin beta-4. Published analytical research has identified TB-500 as the N-terminally acetylated fragment Ac-LKKTETQ.

Full-length thymosin beta-4 has been studied for its influence on cell migration, angiogenesis, and wound repair. Its findings provide biological context, but they should be distinguished from evidence on the shorter TB-500 fragment. The exact sequence and molecular identity of the supplied ingredient should be established through product specifications and analytical documentation.

MGF (Mechano Growth Factor)

MGF research relates to alternative processing of the insulin-like growth factor-1 (IGF-1) gene and synthetic peptides modeled on its E-domain region.

Some studies of synthetic MGF E peptides have reported changes in muscle progenitor cell activation, proliferation, and fusion. Other experiments found no apparent effects on myoblasts or primary muscle stem cells. These differing findings indicate that MGF activity depends on the peptide preparation and experimental model and remains incompletely characterized.

KPV

KPV is a tripeptide composed of lysine, proline, and valine, corresponding to the C-terminal sequence of alpha-melanocyte-stimulating hormone (α-MSH).

In intestinal epithelial and immune cell models, researchers have investigated KPV uptake through the peptide transporter PepT1. Reported effects include reduced activation of NF-κB and MAPK inflammatory signaling and decreased inflammatory cytokine secretion. KPV has also been examined in mouse models of intestinal inflammation.

Chemical Characteristics

Component Compound Description Amount per Vial
BPC-157 Synthetic 15-amino-acid research peptide 10 mg
TB-500 Thymosin beta-4-related research peptide 2.5 mg
MGF Mechano growth factor research peptide 1 mg
KPV Lysine-proline-valine tripeptide 1 mg
Total Four-component research blend 14.5 mg

The blend is a mixture of separate compounds and therefore has no single molecular formula or molecular weight. Component-specific molecular characteristics depend on the exact sequences and chemical forms documented for the supplied materials.

Research Highlights

1. Connective Tissue and Cellular Migration

BPC-157 has been investigated in tendon-derived experimental systems for its effects on fibroblast migration, tendon explant outgrowth, and survival under oxidative stress. These findings support further laboratory investigation of cellular processes involved in connective tissue remodeling.

2. Thymosin-Related Wound Biology

In a rat wound model, full-length thymosin beta-4 increased re-epithelialization, collagen deposition, and angiogenesis. Related cell experiments also demonstrated increased keratinocyte migration. These results concern full-length thymosin beta-4 and do not independently demonstrate equivalent effects from TB-500 or the Wolverine XR blend.

3. Muscle Progenitor Cell Signaling

Synthetic MGF E peptides have been examined for their effects on muscle precursor cells. One study reported increased activation and fusion potential in human muscle progenitor cells, while another found no enhancement of proliferation in the muscle cell models tested. This mixed evidence makes MGF an area of ongoing experimental investigation.

4. Inflammatory Pathway Regulation

KPV has demonstrated anti-inflammatory activity in cell culture and mouse intestinal inflammation models. Investigated mechanisms include PepT1-mediated cellular uptake and modulation of inflammatory signaling. These results provide a basis for studying KPV in defined laboratory systems without establishing clinical benefits for the blend.

5. Multi-Compound Research

Wolverine XR brings together compounds associated with several distinct experimental pathways. Studying them in combination may help researchers examine interactions between cellular migration, muscle cell responses, and inflammatory signaling.

Any additive, synergistic, or antagonistic effects must be measured directly. They cannot be assumed from studies of the ingredients individually.

Conclusion

Wolverine XR is a four-component research blend containing BPC-157 10 mg, TB-500 2.5 mg, MGF 1 mg, and KPV 1 mg. Its components have been investigated across connective tissue, thymosin-related wound biology, muscle progenitor cell, and inflammatory signaling models.

The formulation offers a basis for controlled laboratory investigation of these overlapping research areas. Evidence concerning individual compounds should remain distinct from claims about the finished blend, whose combined biological activity requires direct study.

BPC-157 References

Chang C-H et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology. 2011. PMID: 21030672.

TB-500 and Thymosin Beta-4 References

Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential. 2012. PMID: 22962027.

Malinda KM et al. Thymosin beta4 accelerates wound healing. Journal of Investigative Dermatology. 1999;113(3):364–368. PMID: 10469335.

MGF References

Mechano Growth Factor E peptide (MGF-E), derived from an isoform of IGF-1, activates human muscle progenitor cells and induces an increase in their fusion potential at different ages. PMID: 21354439.

Mechano-growth factor peptide, the COOH terminus of unprocessed insulin-like growth factor 1, has no apparent effect on myoblasts or primary muscle stem cells. PMID: 24253050.

KPV References

Dalmasso G et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008. PMID: 18061177.

Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflammatory Bowel Diseases. 2008;14(3):324–331. PMID: 18092346.

NOTICE OF COMPLIANCE

The mission of BioGenix Peptides | BGX Research is to provide high-quality research compounds that support responsible scientific exploration. Precision, purity, and scientific integrity are central to our commitment to the research community.

This product is supplied exclusively for in-vitro and preclinical research. It is not intended for human consumption, clinical administration, or veterinary use.

The information presented summarizes published research concerning individual ingredients. It does not establish the safety or effectiveness of Wolverine XR or provide instructions for therapeutic use.

Purchasers are responsible for ensuring that handling, storage, and experimental use are appropriate for their research setting and comply with applicable requirements.

Having trouble viewing? Use the buttons below to download or open the certificate.

Download Certificate Open in New Tab

Wolverine XR | BPC-157 10 mg + TB-500 2.5 mg + MGF 1 mg + KPV 1 mg $89.00

In Stock

-
+
You were not leaving your cart just like that, right?

Your Cart Is Still Saved 👀

Don’t lose your saved cart. Enter your email below so your research items are ready whenever you return.

lIMITED tIME rESEARCH aCCESS!

15% Off

      • Use Code: PURE15

BioGenix Peptides

Research Use & Access
Confirmation

Before entering this website, please read and agree
to the following statement:

You are not old enough to view this content.